Prospective, 6 Month, Open Label, Conversion Study From Mycophenolate Mofetil (MMF) to PRMYFORTIC*
NCT00715468
·
clinicaltrials.gov ↗
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Late Complication From Kidney Transplant
Sponsor
Maisonneuve-Rosemont Hospital
Collaborators
[object Object]